Boletín de AInvest
Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
On July 23, 2025,
(BSX) saw a significant surge in trading volume, with a total turnover of $1.62 billion, marking a 97.31% increase from the previous day. This substantial rise in trading volume placed at the 50th position in the daily stock market rankings. The company's stock price also experienced a notable increase, rising by 4.46%.Boston Scientific Corporation reported impressive financial results for the second quarter of 2025. The company's adjusted earnings per share (EPS) reached 75 cents, reflecting a 20.9% year-over-year increase. This strong performance was driven by robust sales growth across all product lines, which surged by nearly 23% to $5.06 billion, surpassing analyst forecasts of $4.89 billion.
The company's positive outlook for the remainder of the year was further reinforced by its revised guidance. Boston Scientific now expects its 2025 adjusted profit to range between $2.95 and $2.99 per share, up from the previous estimate of $2.87 to $2.94 per share. This adjustment reflects the company's confidence in its continued growth and market leadership.
Boston Scientific's strong second-quarter performance was highlighted by a significant increase in net income, which reached $795 million, marking a 146.9% year-over-year increase. This substantial growth in earnings was driven by the company's successful product portfolio and strategic initiatives aimed at expanding its market presence.
Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
Comentarios
Aún no hay comentarios